MedPath

Construction of Gynecological Tumor Organoids

Not yet recruiting
Conditions
Organoid
Gynecologic Cancer
Registration Number
NCT06155370
Lead Sponsor
Peking Union Medical College Hospital
Brief Summary

This study focuses on the construction of a biological sample library for organoids and tumor tissues in gynecological tumors.

Detailed Description

Explore the construction and maintenance of a large-scale queue of gynecological tumor organoids. Beijing Daxiang Technology Co., Ltd. provides corresponding technical support and chip design. Gynecological oncology center provides tumor samples, clinical information, and pathological support, and biological sample library provides technical support, storage space, and quality management.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
200
Inclusion Criteria
  1. Age of 18 or older, an informed consent form is provided;
  2. The preoperative tumor burden assessment and intraoperative researcher team believe that sampling is feasible;
  3. Having relevant requirements for sample library storage;
  4. Surgical treatment at Peking Union Medical College Hospital.
Exclusion Criteria
  1. Unable to meet all inclusion criteria;
  2. The research team considers any situations or considerations that may hinder normal pathological assessment.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Construction of BioBankone year

BioBank including organoids banks, tissue banks, PDX banks, immune cell banks, and primary banks from other tissue sources

Secondary Outcome Measures
NameTimeMethod
Exploring the molecular mechanism based on organoids banksone year

Exploring the molecular mechanism of gynecological tumor pathogenesis based on organoid banks

Drug sensitivity detection based on organoids banksone year

Exploring drug sensitivity detection in gynecological tumors based on organoid libraries

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.